World Library  
Flag as Inappropriate
Email this Article

Metabotropic glutamate receptor 2

Article Id: WHEBN0014474454
Reproduction Date:

Title: Metabotropic glutamate receptor 2  
Author: World Heritage Encyclopedia
Language: English
Subject: Hypothalamic–pituitary–adrenal axis, Metabotropic glutamate receptor, Glutamate receptor, 5-HT2A receptor, Biphenylindanone A, APICA (drug), LY-404,039
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Metabotropic glutamate receptor 2

Glutamate receptor, metabotropic 2
Identifiers
Symbols GRM2; GLUR2; GPRC1B; MGLUR2; mGlu2
External IDs OMIM: GRM2 Gene
RNA expression pattern
PBB GE GRM2 208465 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 2912 108068
Ensembl ENSG00000164082 ENSMUSG00000023192
UniProt Q14416 Q14BI2
RefSeq (mRNA) NM_000839 NM_001160353
RefSeq (protein) NP_000830 NP_001153825
Location (UCSC) Chr 3:
51.74 – 51.75 Mb
Chr 9:
106.64 – 106.66 Mb
PubMed search [1] [2]

Metabotropic glutamate receptor 2 is a protein that in humans is encoded by the GRM2 gene.[1][2]

Function

L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 (this receptor) and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities.[2]

Ligands

The development of subtype-2-selective positive allosteric modulators (PAMs) experienced steady advance in recent years.[3] mGluR2 potentiation is a new approach for the treatment of schizophrenia.[4] On the other hand, antagonists and negative allosteric modulators of mGluR2/3 have potential as antidepressant drugs.[5][6][7][8]

PAMs

  • ADX-71149[10]
  • GSK1331258[11]
  • Imidazo[1,2-a]pyridines[12]
  • 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones[13]
  • 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: potent, orally stable[14]
  • BINA:[15][16] potent; modest ago-allosteric modulator; robust in-vivo activity.
  • LY-487,379:[17][18][19] devoid of orthosteric activity; along with related 3-pyridylmethylsulfonamides[20][21] the first subtype-2-selective potentiator published (2003).

Antagonists

NAMs

  • 7,8-dichloro-4-[3-(2-methylpyridin-4-yl)phenyl]-1,3-dihydro-1,5-benzodiazepin-2-one and related compounds.[22]
  • MNI-137 - 8-bromo-4-(2-cyanopyridin-4-yl)-1H-benzo[b][1,4]diazepin-2(3H)-one[23]
  • RO4491533 - 4-[3-(2,6-dimethylpyridin-4-yl)phenyl]-7-methyl-8-trifluoromethyl-1,3-dihydrobenzo[b][1,4]diazepin-2-one[24]

See also

References

External links

  • This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
     
    Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
     
    By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
     


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.